Galangin for COVID-19 and Mucormycosis co-infection: a potential therapeutic strategy of targeting critical host signal pathways triggered by SARS-CoV-2 and Mucormycosis
Article in Network Modeling Analysis in Health Informatics and Bioinformatics (June 2023)